Dow Jones 30 Stocks SEC Filings — February 01, 2026

02-02-2026

Aptiv PLC filed an 8-K on February 2, 2026 (AccNo: 0001521332-26-000004), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

02-02-2026

Fifth Third Bancorp filed an 8-K on 2026-02-02 reporting completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), departure of directors/officers, election of directors, appointment of officers, and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, synergies, or impacts were disclosed, resulting in no identifiable positive or negative performance indicators.

02-02-2026

02-02-2026

02-02-2026

Planet Green Holdings Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information.

02-02-2026

Avalon GloboCare Corp. filed a Form 8-K on February 2, 2026 (AccNo: 0001213900-26-010568, size 211 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or numerical data are disclosed in the provided filing information. This appears to be a multi-item, likely voluntary disclosure related to Regulation FD.

02-02-2026

Nine Energy Service, Inc. filed an 8-K on 2026-02-02 reporting bankruptcy or receivership under Item 1.03, alongside entry into a material definitive agreement (Item 1.01), creation of direct financial obligations (Item 2.03), and triggering events accelerating obligations (Item 2.04). Additional disclosures include Regulation FD information (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

02-02-2026

Spring Valley Acquisition Corp. II filed an SEC document on 2026-02-02 (AccNo: 0001104659-26-008851, size 13 MB) related to a Merger/Acquisition event dated February 02, 2026. No deal structure, parties beyond the filer, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or sector implications are disclosed. No quantitative metrics, comparisons, or scheduled events are mentioned.

• ·Accession Number: 0001104659-26-008851
• ·Filing source: us_sec

02-02-2026

SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.

• ·Event date: February 02, 2026
• ·Accession Number: 0001829126-26-000831
• ·File size: 194 KB
• ·Sector: NOT_DISCLOSED

02-02-2026

Toppoint Holdings Inc. filed an 8-K on 2026-02-02 reporting entry into a Material Definitive Agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, personnel names, or impacts are disclosed.

02-02-2026

02-02-2026

Global Net Lease, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-008874, Size: 381 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Reg FD and attached exhibits. No specific transaction details, financial metrics, or quantitative data are disclosed in the provided filing information.

02-02-2026

PotlatchDeltic Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in control of the registrant under Item 5.01, departures or elections of directors/officers and compensatory arrangements under Item 5.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03. Item 9.01 includes financial statements and exhibits. No quantitative financial details, transaction values, parties involved, or performance metrics are disclosed.

02-02-2026

Two Harbors Investment Corp. filed an 8-K on February 2, 2026 (AccNo: 0001465740-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

02-02-2026

Walt Disney Co filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard multi-item earnings-related filing. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary.

02-02-2026

Venture Global, Inc. filed a Form 8-K on 2026-02-02 under Item 1.01 disclosing entry into a material definitive agreement. No specific details on the agreement's parties, transaction value, financial terms, strategic rationale, or impacts were provided. This mandatory disclosure signals a potentially significant event, but lacks quantitative data for impact assessment.

02-02-2026

REVVITY, INC. filed an 8-K on 2026-02-02 disclosing Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

02-02-2026

Aquestive Therapeutics, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001398733-26-000005, size 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing provides voluntary public disclosure of potentially material information with attached exhibits. No specific financial metrics, transactions, events, or directional data are disclosed in the filing summary.

02-02-2026

Veeco Instruments Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events. No specific details on the core event, transaction values, financial metrics, or quantitative data were disclosed in the filing summary. This is a single-item informational disclosure with no directional financial implications evident.

02-02-2026

VSE Corp filed Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events, indicating a material event deemed important by the company, accompanied by Item 9.01 Financial Statements and Exhibits listing attached documents. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing metadata. This appears to be a multi-item informational filing with no quantified positive or negative impacts reported.

02-02-2026

Huntington Bancshares Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific transaction details, parties, financial metrics, or performance comparisons are disclosed.

• ·Filing Accession Number: 0001140361-26-003083
• ·File size: 318 KB
• ·No quantitative metrics, deal size, parties beyond filer, or performance data disclosed

02-02-2026

DOW INC. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing where specific details of the other events and any attached financial statements or exhibits are NOT_DISCLOSED in the provided information. No quantitative metrics, transactions, or directional impacts are mentioned.

• ·AccNo: 0001751788-26-000015
• ·File Size: 908 KB

02-02-2026

Perspective Therapeutics, Inc. filed an 8-K on February 02, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results, but specific metrics, transaction details, and performance data are NOT_DISCLOSED. No quantitative financial impacts, period-over-period comparisons, or guidance revisions are provided in the available information.

02-02-2026

Clarivate PLC filed a Form 8-K on 2026-02-02 disclosing the termination of a material definitive agreement under Item 1.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the agreement counterparty, termination reasons, financial impacts, or strategic effects were provided. No quantitative metrics, period-over-period comparisons, or performance data were mentioned.

02-02-2026

Wave Life Sciences Ltd. filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-032698), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing with no evident positive or negative performance indicators.

02-02-2026

Quaint Oak Bancorp, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0000927089-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing for financial results announcement. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are detailed in the provided filing information.

02-02-2026

Skyline Bankshares, Inc. filed a Form 8-K on 2026-02-02 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific quantitative financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other numerical data were explicitly stated in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

02-02-2026

Sierra Bancorp filed an 8-K on 2026-02-02 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or other quantitative financial details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

02-02-2026

Devon Energy Corp filed a multi-item 8-K on February 2, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No quantitative details, transaction values, personnel names, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This requires review of exhibits for full context.

02-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001731122-26-000164, Size: 96 MB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely containing material disclosures and exhibits, but specific details of events, financials, or metrics are NOT_DISCLOSED in the provided information. No quantitative data, performance metrics, positive or negative changes, or directional implications extracted.

02-02-2026

Carter Bankshares, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. All impacts, changes, and scheduled events are NOT_DISCLOSED.

02-02-2026

INNOVATE Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited disclosure available.

02-02-2026

Flowco Holdings Inc. filed a Form 8-K on February 02, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant corporate developments, but lacks substantive content for deeper assessment.

02-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001493152-26-004655, Size: 200 KB), reporting solely under Item 8.01 Other Events. No details on the core event, transaction, financial metrics, or impacts are disclosed in the provided information. This single-item filing represents a mandatory disclosure of material information not covered by other 8-K items.

02-02-2026

VerifyMe, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a multi-item, primarily voluntary disclosure as Item 8.01 covers uncategorized material events.

02-02-2026

Cadre Holdings, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 the entry into a material definitive agreement. Item 9.01 indicates financial statements and exhibits are included. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.

02-02-2026

Northfield Bancorp, Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, transaction values, or quantitative metrics are provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative financial metrics.

02-02-2026

NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.

02-02-2026

Inuvo, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001654954-26-000799, Size: 146 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure as Item 8.01 covers company-deemed material events not specified elsewhere. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

02-02-2026

Plumas Bancorp filed a Form 8-K on February 02, 2026 (AccNo: 0001437749-26-002609, Size: 182 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. This multi-item filing appears informational with no quantified positive or negative metrics provided.

02-02-2026

Barnwell Industries Inc filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement, modifications, events, transaction values, financial impacts, or quantitative metrics. No positive or negative performance metrics are disclosed.

02-02-2026

Ondas Holdings Inc. filed an 8-K on February 02, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing summary. Critical content from the exhibits or disclosures is missing, limiting assessment of impact.

02-02-2026

F&M BANK CORP filed an 8-K on February 2, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

02-02-2026

Advanced Drainage Systems, Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.

02-02-2026

Oppenheimer Holdings Inc filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004480, Size: 2 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of material information, likely accompanied by exhibits such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata.

02-02-2026

CAPITAL CITY BANK GROUP INC filed an 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the filing summary.

02-02-2026

International Bancshares Corp filed a Form 8-K on February 02, 2026 (AccNo: 0001104659-26-009083, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or directional impacts are mentioned.

02-02-2026

OptimumBank Holdings, Inc. filed a Form 8-K on 2026-02-02 reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

02-02-2026

KBS Real Estate Investment Trust III, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the transaction, parties, dollar values, terms, or financial impacts were provided in the filing summary. This multi-item filing appears related to a financing event typical for REITs, with no positive or negative metrics disclosed.

02-02-2026

PROVECTUS BIOPHARMACEUTICALS, INC. filed a Form 8-K on 2026-02-02 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 Financial Statements and Exhibits. No specific details on the nature, effective date, or impact of the amendments or changes are provided. No quantitative financial metrics, positive or negative changes, or other performance data are mentioned.

02-02-2026

DaVita Inc. filed an 8-K on February 2, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were mentioned in the filing summary provided. This appears to be a standard earnings-related disclosure without detailed performance data.

02-02-2026

FRANKLIN FINANCIAL SERVICES CORP /PA/ filed an 8-K on February 02, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific core event, transaction details, financial metrics, or quantitative data disclosed in the provided filing information. Content of the disclosure and exhibits is NOT_DISCLOSED.

02-02-2026

02-02-2026

FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

02-02-2026

Vaxcyte, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), indicating disclosure of a material event and related exhibits. Specific details of the other events, financial impacts, or metrics are NOT_DISCLOSED in the provided filing summary. No quantitative data, positive or negative metrics, or performance comparisons were mentioned.

02-02-2026

MGIC Investment Corp filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, or other metrics detailed in the provided filing information. No positive or negative performance indicators, comparisons, or guidance were mentioned.

• ·Accession Number: 0000876437-26-000006
• ·File Size: 911 KB
• ·Sector: not specified

02-02-2026

Shore Bancshares Inc filed an 8-K on February 02, 2026 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or other quantitative details are disclosed in the filing summary provided. No positive or negative performance indicators are mentioned.

02-02-2026

Peoples Bancorp Inc filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing to disclose material non-public information in compliance with Regulation FD and attach relevant exhibits. No financial metrics, transactions, or other quantitative details are explicitly stated in the filing summary provided.

02-02-2026

Joby Aviation, Inc. filed a Form 8-K on 2026-02-02 reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), with Item 9.01 for Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, financial results, obligation terms, dollar values, or impacts are NOT_DISCLOSED.

02-02-2026

Palomar Holdings, Inc. filed an 8-K on February 02, 2026, disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, synergies, or financial impacts are disclosed in the provided filing summary. Critical transaction details remain NOT_DISCLOSED, limiting assessment of shareholder or market implications.

02-02-2026

vTv Therapeutics Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 its entry into a Material Definitive Agreement. No details on the core event, transaction parties, dollar value, financial impacts, or strategic importance are provided in the available information. No quantitative metrics, guidance changes, or scheduled events are mentioned.

02-02-2026

FIRST FINANCIAL BANCORP /OH/ filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 9 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to comply with Regulation FD, potentially including attached exhibits such as presentations.

• ·AccNo: 0000708955-26-000011
• ·Filing size: 9 MB
• ·Event Type: General Filing
• ·Multi-item 8-K: Items 7.01 and 9.01

02-02-2026

AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.

02-02-2026

S&T Bancorp Inc filed an 8-K on February 2, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or period-over-period comparisons are disclosed in the provided filing information.

02-02-2026

Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

02-02-2026

NightFood Holdings, Inc. filed an 8-K on February 02, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are explicitly stated in the filing summary. No quantitative data, period-over-period comparisons, or material events are disclosed.

02-02-2026

EVERTEC, Inc. filed a Form 8-K on 2026-02-02 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing covering a core material event with attached exhibits. No specific details on the agreement terms, financial impacts, or quantitative metrics are disclosed in the provided information.

02-02-2026

Bark, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004626), disclosing an unspecified event under Item 8.01 (Other Events). No financial metrics, transaction details, quantitative data, positive or negative changes, or operational impacts were mentioned. Sector information was not specified.

02-02-2026

Third Coast Bancshares, Inc. filed an 8-K on February 2, 2026, disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative metrics, transaction details, or performance comparisons are explicitly stated.

02-02-2026

Goldman Sachs Group Inc filed an 8-K on February 2, 2026, solely under Item 9.01 Financial Statements and Exhibits, indicating attachment of unspecified financial statements or exhibits (file size 344 KB). No specific events, transactions, metrics, or details are disclosed in the filing summary. This appears to be an informational exhibit filing with no directional financial impact evident.

02-02-2026

Veradigm Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, or disclosures are provided in the filing summary. No quantitative financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed.

02-02-2026

Goldman Sachs BDC, Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

02-02-2026

Prosperity Bancshares Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items, and Item 9.01 Financial Statements and Exhibits, indicating attached documents such as press releases or agreements. No specific details on the nature of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is an informational filing with no quantitative data or directional implications available.

02-02-2026

Advanced Biomed Inc. filed a Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing signals a potentially strategic transaction alongside possible dilutive equity issuance, but specific terms, values, or impacts remain undisclosed. No quantitative financial metrics, guidance changes, or performance comparisons are provided.

02-02-2026

APARTMENT INVESTMENT & MANAGEMENT CO filed a Form 8-K on February 02, 2026, disclosing an unspecified Other Event under Item 8.01. No quantitative data, financial impacts, transaction details, or other metrics are mentioned in the filing information provided. This is a voluntary single-item disclosure with no further specifics on the event.

02-02-2026

Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.

02-02-2026

Avidia Bancorp, Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

02-02-2026

Farmers & Merchants Bancorp filed a Form 8-K on February 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing material non-public information previously disclosed selectively, with supporting exhibits attached. No specific financial metrics, transactions, or performance details are disclosed in the filing summary.

02-02-2026

RCI Hospitality Holdings, Inc. filed Form 8-K on 2026-02-02 under Item 3.01 announcing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No specific reasons, timelines, financial impacts, or quantitative details are provided.

02-02-2026

EverSpin Technologies Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004681, Size: 142 KB), reporting under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No positive, negative, or flat performance metrics are mentioned.

02-02-2026

Esquire Financial Holdings, Inc. filed an 8-K on February 2, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are provided. This appears to be a voluntary informational filing with no quantified financial metrics or directional impacts disclosed.

02-02-2026

AIxCrypto Holdings, Inc. filed an 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or directional impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantified positive or negative metrics available.

02-02-2026

Atkore Inc. filed an 8-K on February 2, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 discloses financial statements and exhibits were attached. No vote outcomes, numerical results, financial metrics, or directional impacts provided in the filing details.

02-02-2026

MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

02-02-2026

International Business Machines Corp (IBM) filed an 8-K on February 2, 2026, solely under Item 9.01: Financial Statements and Exhibits. No specific financial metrics, transactions, period-over-period comparisons, or material events are disclosed in the filing details provided. This is an informational filing with attached exhibits but lacks quantitative data or directional impacts.

02-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.